troglitazone has been researched along with Nausea in 1 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Troglitazone was effective in 394 (75%) of the 529 patients for whom an opinion was given." | 1.31 | Troglitazone and liver function abnormalities: lessons from a prescription event monitoring study and spontaneous reporting. ( Biswas, P; Shakir, SA; Wilton, LV, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biswas, P | 1 |
| Wilton, LV | 1 |
| Shakir, SA | 1 |
1 other study available for troglitazone and Nausea
| Article | Year |
|---|---|
Troglitazone and liver function abnormalities: lessons from a prescription event monitoring study and spontaneous reporting.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Chromans; England; Fatigue; Female; Humans; Hyp | 2001 |